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Abstract
Background
Guidelines recommend implementation of multimodal interventions to help prevent recur-
rent TIA/stroke. We undertook a systematic review to assess the effectiveness of behavioral
secondary prevention interventions.
Strategy
Searches were conducted in 14 databases, including MEDLINE (1980-January 2014). We
included randomized controlled trials (RCTs) testing multimodal interventions against usual
care/modified usual care. All review processes were conducted in accordance with
Cochrane guidelines.
Results
Twenty-three papers reporting 20 RCTs (6,373 participants) of a range of multimodal be-
havioral interventions were included. Methodological quality was generally low. Meta-analy-
ses were possible for physiological, lifestyle, psychosocial and mortality/recurrence
outcomes. Note: all reported confidence intervals are 95%. Systolic blood pressure was re-
duced by 4.21 mmHg (mean) (−6.24 to −2.18, P = 0.01 I2 = 58%, 1,407 participants); dia-
stolic blood pressure by 2.03 mmHg (mean) (−3.19 to −0.87, P = 0.004, I2 = 52%, 1,407
participants). No significant changes were found for HDL, LDL, total cholesterol, fasting
blood glucose, high sensitivity-CR, BMI, weight or waist:hip ratio, although there was a sig-
nificant reduction in waist circumference (−6.69 cm, −11.44 to −1.93, P = 0.006, I2 = 0%, 96
participants). There was no significant difference in smoking continuance, or improved fruit
and vegetable consumption. There was a significant difference in compliance with antith-
rombotic medication (OR 1.45, 1.21 to 1.75, P<0.0001, I2 = 0%, 2,792 participants) and
with statins (OR 2.53, 2.15 to 2.97, P< 0.00001, I2 = 0%, 2,636 participants); however,
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there was no significant difference in compliance with antihypertensives. There was a signif-
icant reduction in anxiety (−1.20, −1.77 to −0.63, P<0.0001, I2 = 85%, 143 participants).
Although there was no significant difference in odds of death or recurrent TIA/stroke, there
was a significant reduction in the odds of cardiac events (OR 0.38, 0.16 to 0.88, P = 0.02,
I2 = 0%, 4,053 participants).
Conclusions
There are benefits to be derived from multimodal secondary prevention interventions. How-
ever, the findings are complex and should be interpreted with caution. Further, high quality
trials providing comprehensive detail of interventions and outcomes, are required.
Review Registration
PROSPERO CRD42012002538.
Introduction
Stroke, a chronic, debilitating condition, is projected to remain one of the leading causes of
death and adult disability for the foreseeable future [1]. Annually, approximately 15 million
people worldwide have a stroke; approximately one third will die and one third will be left per-
manently disabled [1]. Without intervention, it is projected that, globally, deaths caused by
stroke will rise to 7.8 million in 2030 [2]; the number of living stroke survivors is expected to
rise to 77 million [2]. Following transient ischaemic attack (TIA) or stroke, rates of recurrence
are high: 8.1% within 48 hours following TIA [3], and at 10 years following stroke the cumula-
tive risk of recurrence is 39.2% [4]. Such high rates of recurrence indicate the need for early im-
plementation of effective secondary prevention measures that address modifiable risk factors
including: hypertension, abnormal blood lipids, smoking, diet, physical activity, alcohol con-
sumption, and psychosocial stress and depression [5]. Evidence-based clinical guidelines rec-
ommend implementation of multimodal approaches to secondary prevention [6,7] i.e.
complex interventions that address all of the following: prescription of appropriate medication
in conjunction with active provision of information and education regarding stroke, lifestyle
(behavioral) risk factors, and medication adherence. To enhance effectiveness and maximise
the potential for patient compliance, it is further recommended that such interventions be in-
formed by behavior change theory and make use of behavior change techniques, such as moti-
vational interviewing [8].
While there is a strong impetus for the implementation of multimodal interventions, under-
standing of the effectiveness of such interventions and the processes involved in supporting the
initiation and subsequent maintenance of behavior change is limited [9]. Previously published
literature reviews have been narrow in scope, or have focussed only on particular elements of
intervention e.g. exercise [9, 10–13]. Consequently, there remains a gap in knowledge regard-
ing the effectiveness of multimodal interventions. Therefore, to begin to address this evidence
gap, we undertook a systematic review to determine the effectiveness of multimodal secondary
prevention interventions following TIA and/or stroke. Future work will focus on unpicking the
detail of the prcesses and mechanisms of action.
Stroke Secondary Prevention: Systematic Review
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Methods
The review was conducted as described in a protocol registered with PROSPERO (CRD420
12002538; S1 Text) using Cochrane Collaboration methods [14], and is reported here in accor-
dance with PRISMA guidelines [15] (S1 PRISMA Checklist). All screening, extraction and as-
sessment processes were conducted by two of four reviewers (ML, JP, SK, JB) working
independently; any disagreements were resolved by consensus, with arbitration by a third re-
viewer, if necessary.
Inclusion criteria
We determined inclusion criteria relating to Participants, Interventions, Comparator and Out-
comes (PICO; S1 Box) [16]; all included studies were randomized controlled trials (RCTs).
Study participants were required to be adults aged18 years who had had a stroke. A broad
definition of stroke was adopted, to include ischaemic stroke, haemorrhagic stroke, subarach-
noid haemorrhage and TIA [17] (Hanto, 1976). In terms of intervention, stroke secondary pre-
vention interventions were required to be ‘multimodal’. Multimodal was defined as a complex
intervention which addresses: 1) medication education and/or medication compliance educa-
tion; 2) education or active information provision e.g. about stroke, stroke (lifestyle) risk fac-
tors; and 3) one or more of four specified lifestyle behaviors i.e. smoking, diet, physical
inactivity, and alcohol consumption, and/or behaviors associated with amelioration of lifestyle
risk factors i.e. medication compliance and management of perceived psychosocial stress.
Comparator was usual care or modified usual care e.g. a schedule of phone calls that mimics
the schedule of ‘intervention’ calls made to the intervention group. Primary outcomes of inter-
est included physiological outcomes e.g. blood pressure, blood lipids, and lifestyle behavior
change. Secondary outcomes of interest were psychosocial outcomes e.g. anxiety, learning out-
comes e.g. knowledge of lifestyle risk factors for stroke, and incidence of vascular events and
mortality. The latter were described as secondary outcomes rather than primary outcomes be-
cause, despite their clinical importance, few studies report long-term follow-up data, 3–6
months being the most frequently reported follow-up period.
Database and Search Strategies
In January 2014, searches were conducted in a comprehensive range of electronic databases i.e.
AMED, ASSIA, CINAHL, Cochrane Central Register of Controlled Trials, Cochrane DARE,
DORIS, Embase, ERIC, EThOS, Health Management Information Consortium, Medline, Psy-
cINFO, Social Services Abstracts, and ZETOC. Selected medical subject headings (MeSH) were
combined with keywords relating to stroke, secondary prevention, and specific lifestyle behav-
iors i.e. smoking, physical inactivity, diet, alcohol and perceived psychosocial stress, to create a
search strategy, finalised for use in MEDLINE (S2 Text), and amended for use in the other da-
tabases, using appropriate controlled vocabulary, Boolean operators and search symbols. De-
limiters were: dates searched (1980–2014); research subjects (human); and language (English).
In addition, we scanned the reference lists of relevant papers, including systematic reviews, for
potentially relevant studies. Bibliographic management software, RefWorks, was used to store
and manage the results of the database searches.
Data Extraction and Quality Assessment
Data, including details of study design and methods, study populations, interventions (delivery
and content), and primary and secondary outcomes, were extracted from papers using a data
extraction tool adapted for this review from our earlier review [11] (S3 Text). Authors were
Stroke Secondary Prevention: Systematic Review
PLOSONE | DOI:10.1371/journal.pone.0120902 March 20, 2015 3 / 25
contacted to request provision of any missing data. Methodological quality was assessed using
the Cochrane Risk of Bias tool [14]. Quality was assessed as being of low/unclear/high risk of
bias against seven criteria: random sequence generation (selection bias), allocation conceal-
ment (selection bias), blinding of assessors (performance bias), blinding of outcome assessment
(detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias),
and ‘other’.
Data analysis
We calculated the differences between intervention and control groups, post-intervention.
Continuous outcome measures were expressed as mean value post treatment in each group
and variances were derived from standard deviations. These data were analysed using fixed ef-
fects inverse-variance meta-analysis for difference in means between intervention and control
groups with 95% confidence interval (CI). The fixed effect model is the best model to use if (a)
there is reason to believe that all the studies are functionally identical, (b) our goal is to com-
pute the common effect size, which would then be generalized to other examples of this same
population, (c) there are no studies with extreme effect sizes that could influence the results, or
(d) the number of studies is very small, meaning it may be difficult to estimate the between-
studies variance (the extra variance added in the random effects model) with any precision. It
is reasonable to assume that the studies included in our analysis are estimating the same effect
size, and our goal is to compute this common effect.
Where post treatment outcomes were measured more than once, we used the later measure-
ment. To determine long-term effectiveness of interventions, we conducted sub-analysis for
the follow-up point for which most data were available i.e. 12 months. Dichotomous outcomes
were analysed using fixed effects Mantel-Haenszel meta-analysis with odds ratios (ORs) and
95% CI. Heterogeneity was assessed using I2; heterogeneity>50% was considered noteworthy
[14]. We used Review Manager v.5.1 [18] to perform our statistical analyses. The focus of sec-
ondary prevention intervention is on initiation of behaviors that will help to reduce the risk of
recurrence of stoke and other cardiovascular events, with the aim of sustaining the benefits of
intervention in the long-term. Therefore meta-analyses were conducted on all available data, ir-
respective of data collection time point and sub-analyses were conducted where 12-month data
were available. Note: all data are reported with 95% CIs.
Results
Description of Included Trials
Database searches identified 9,098 unique bibliographic references. Review of title and ab-
stracts resulted in the exclusion of 9,028 papers that did not meet the broad inclusion criteria
(TIA/stroke; RCT). Full texts were retrieved for the remaining 70 papers, and for an additional
26 papers identified by the grey literature searches (i.e. n = 96). These papers were screened for
eligibility using the detailed PICO criteria. This resulted in the exclusion of 73 papers; 23 pa-
pers were included in the review (Fig. 1). Papers were rejected because they were not RCTs
(n = 24), included populations other than stroke (n = 1), were not multimodal secondary pre-
vention interventions (n = 22), or did not report relevant outcomes (n = 26).
The 23 papers reported 20 RCTs. Extracted data from the 23 papers are presented in the evi-
dence table (Table 1), however not all of these papers reported data in a format that facilitated
inclusion in the meta-analyses reported below. Ellis et al., (2005) and McManus et al., (2009)
reported the same nurse-led study, Ellis et al., at three-month follow-up, McManus et al., at
36-months, therefore, for the purposes of this review, they were considered as one paper
[19,20]. Faulkner et al., (2103a) and Faulkner et al., (2013b) both reported HEPAP, an
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exercise-based intervention [21,22]. Intervention details were extracted from both papers; re-
sults were taken from the 2013b paper [22]. Goldfinger et al., (2012) and Horowitz et al.,
(2013) reported the same community-based intervention (PRAISE) [23,24]. Intervention de-
tails were extracted from both papers; previously unpublished results were provided by the au-
thors [25].
Of the 20 trials (6,373 participants at baseline), four were conducted in Asia [26–30], four in
Australasia [21,22,30–32], seven in Europe [19,20,33–38] and five in North America [23–
25,39–42]. Reported mean ages of participants ranged from 55–74 years. Nineteen trials in-
cluded participants of both sexes; one did not report the gender of participants [40]. ‘Usual
care’ was the comparator in 16 trials; however, in one six-month long intervention, control par-
ticipants were provided with study information and educational materials at two-monthly
Fig 1. Details of the Flow of Papers through the Review Process.
doi:10.1371/journal.pone.0120902.g001
Stroke Secondary Prevention: Systematic Review
PLOSONE | DOI:10.1371/journal.pone.0120902 March 20, 2015 5 / 25
Table 1. Evidence table: participant details and study characteristics.
Authors, Year,
Country
Study participants Intervention type Theory/
Model
Intervention initiation,
frequency, duration
Data collection times
Outcomes of interest
Completers; Signiﬁcant
results at ﬁnal follow-up
Adie & James
2010 UK
I: n = 29, Male: 12;
Age: 73.6 (SD 8.0);
C: n = 27, Male: 16;
Age: 71.2 (SD 9.7)
1 to 1; Telephone-based
education, advice &
counseling; Social
Cognitive Theory
7–10 days post-stroke;
Initial telephone
counseling (one-off
session) & then at 1, 2
& 4 months post-stroke
Baseline & 6 months;
BP, cholesterol, change
in medication
knowledge, smoking,
diet, exercise
Completers: I: 29; C: 27 I:
non-signiﬁcant reduction
in cholesterol, signiﬁcant
medication knowledge;
no other signiﬁcant
results
Allen et al., 2009
USA
I: n = 190, Male: 91
Age: 68 (SE 1) C:
n = 190; Male: 99
Age: 69 (SE 1)
1 to 1; Care management
approach; Chronic illness
model
In-home assessment
1 week of discharge;
Telephone contact
weekly (1 month), then
monthly (6 months);
home visits as required
Baseline & 6 months
BP, cholesterol, HbA1c,
lifestyle modiﬁcation,
stroke knowledge, QoL
Completers: I: 163; C:
175; I: signiﬁcant effect
on lifestyle modiﬁcation
(p = 0.0003) and stroke
knowledge (p = 0.0003);
no other signiﬁcant
results
Banet & Felchlia,
1997; USA
I: n = 28, Male: NR
Age: NR; C: n = 28,
Male: NR; Age: NR
1 to 1; Patient-held shared
medical records &
education pack Theory:
NR
At discharge Individual
supported to record
behavioral goals &
keep records updated;
followed up for 6
months
Baseline & 6 months
Miller’s Intention Scale &
Behavior Scale for diet,
smoking & exercise
Completers: I: 24; C: 28
No signiﬁcant results
Chanrueng-
vanich et al.,
2006 Thailand
I: n = 31, Male: 10
Age: 62.8 (SD 7.4);
C: n = 31, Male: 10;
Age: 63.2 (SD 7.1)
Group education then self-
regulation; Social
Cognitive Theory & Health
Promotion Model
 6 weeks post-stroke;
12-week education &
exercise programme
Baseline, 6 & 12 weeks;
HR, BP, ﬁbrinogen,
cholesterol, physical
activity questionnaire
Completers: I: NR; C:
NR; No signiﬁcant results
Damush et al.,
2011 USA
I: n = 87, Male: NR;
Age: NR; C: n = 87,
Male: NR; Age: NR
Format: NR; Social
Cognitive Theory & self-
management
 1 month post-
discharge Telephone
support biweekly for 12
weeks
Baseline, 3 & 6 months
SSQoL, Self-
Management Behavior
Frequency, medication
compliance
Completers: I & C: 123;
No signiﬁcant results
Eames et al.,
2013 Australia
I: n = 71 (31 carers,
40 pats), Male: 38;
Age: 55.2 (SD 16.7);
C: n = 67 (30 carers,
37 patients), Male: 31
Age: 61.4 (SD 12.7)
1 to 1/dyad Computer-
generated tailored
information booklet &
verbal reinforcement
Health Belief Model &
principles of adult learning
Recruited prior to
discharge; Monthly
phone calls for 3
months
Baseline & 3 months
Stroke Knowledge, self-
efﬁcacy, SA-QoL,
Anxiety
Completers: I: 60; C: 59 I:
improved self-efﬁcacy for
accessing stroke
information (p = 0.004) &
feeling informed
(p = 0.008); There were
no other signiﬁcant
results
Ellis et al., 2005 /
McManus et al.,
2009 UK
I: n = 49, Male: NR
Age: NR; C: n = 53,
Male: NR; Age: NR
1 to 1/dyad; Health
education & counselling
Theory: NR
 3 months post-
stroke; Counselling
interviews, monthly for
3 months
Baseline, 5 months &
3.6 years; BP, HbA1c,
cholesterol, smoking,
QoL, depression,
survival
Completers: I: 49: C: 53;
No signiﬁcant results
Faulkner et al.,
2013a/ Faulkner
et al., 2013b;
New Zealand
I: n = 33, Male: 16
Age: 68 (SD 11) C:
n = 37, Male: 15 Age:
69 (SD 10)
Group exercise &
education Individual
exercise prescription;
Health Belief Model
 2 weeks post-onset;
2 sessions per week
for 8 weeks: 90
minutes exercise, 30
minutes education
Baseline, 2 & 3 months
BP, HbA1c, cholesterol,
BMI, waist
circumference, smoking
Completers: I: 30; C: 30 I:
signiﬁcant improvement
in systolic BP (p = <0.5);
no other signiﬁcant
results
Flemming et al.,
2013; USA
I: n = 20, Male: 10
Age: 73.3 (SD 13) C:
n = 21, Male: 14 Age:
71.0 (SD 9)
1 to 1; Education, goal
planning, motivational
interviewing; Theory: NR
< 12 weeks post-
onset; Visits at
baseline, 6 weeks, 6 &
12 months; Phone calls
at 3 & 9 months
Baseline, 6 & 12
months; BP, HbA1c,
cholesterol, BMI,
physical activity
frequency, alcohol &
tobacco use, diet
Completers: I: 18; C: 18;
I: signiﬁcant improvement
in systolic LDL
(p = 0.0083); no other
signiﬁcant results
Gillham &
Endacott, 2010;
UK
I: n = 26, Male: NR
Age: 67.7 (SD 12.0);
C: n = 26, Male: NR;
Age: 68.9 (SD 13.2)
1 to 1; Education &
support; Transtheoretical
model
Time post-stroke: NR;
Initial interview then MI
telephone follow-up at
2 & 6 weeks
Baseline & 3 months
HADS, Readiness to
change, alcohol,
smoking, exercise, diet
Completers: I: 25; C: 25 I:
signiﬁcant improvement
in self-reported exercise
(p = 0.007) & diet
(p = 0.033); no other
signiﬁcant results
(Continued)
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Table 1. (Continued)
Authors, Year,
Country
Study participants Intervention type Theory/
Model
Intervention initiation,
frequency, duration
Data collection times
Outcomes of interest
Completers; Signiﬁcant
results at ﬁnal follow-up
Goldﬁnger et al.,
2012 (protocol)/
Horowitz et al.,
2013/Negron
et al. 2014; USA
I: n = NR, Male: NR
Age: NR; C: n = NR,
Male: NR Age: N
Community groups;
PRAISE (Prevent
Recurrence of All Inner-city
Strokes through
Education) Education &
self-management (peer-
led); Theory: NR
1.8 years (SD 1.5)
Weekly workshops for
6 weeks
Baseline & 6 months
BP, LDL, weight, BMI,
medication compliance,
smoking, alcohol,
knowledge, HRQoL,
stress
Completers: I: 242; C:
266; I: signiﬁcant
improvement in systolic
BP and diastolic BP
Hornnes et al.,
2011 Denmark
I: n = 172, Male: 76
Age: 70.2 (SD 13.7);
C: n = 177, Male: 79;
Age: 68.5 (SD 12.2)
1 to 1; PREVENT (Post-
Stroke Preventive Trial)
Education, counselling;
Behavioral counseling
Pre-discharge or at ﬁrst
OPD appointment
Home visits at 1, 4, 7 &
10 months
Baseline & 1, 4, 7 & 12
months; BP, medication
compliance, recurrent
event
Completers: I: 145; C:
158; I: signiﬁcant
improvement in BP
(p = 0.007); no other
signiﬁcant results
Joubert et al.,
2006 Australia
I: n = 46, Male: 23
Age: 64.7 (SD 14.9);
C: n = 51, Male: 25;
Age: 68.2 (SD 12.5)
1 to 1/dyad Integrated
shared-care model Theory:
NR
Post-discharge GP
visits at 2 weeks, 3, 6,
9, & 12 months
Telephone assessment
prior to each visit;
information to GP
Baseline & 12 months
BP, cholesterol, blood
glucose, BMI, exercise,
smoking, alcohol
Completers: I: 35; C: 45 I:
signiﬁcant improvement
in cholesterol (p = 0.02) &
exercise (p = 0.048); no
other signiﬁcant results
Joubert et al.,
2009 Australia
I: n = 123, male: 53
Age: 63.4 (SD 13.7);
C: n = 110, Male: 49;
Age: 68.2 (SD 12.7)
1 to 1/dyad ICARUSS
(Integrated Care for the
reduction of Secondary
Stroke); Theory: NR
Post-discharge GP
visits at 2 weeks, 3, 6,
9, & 12 months
Telephone assessment
prior to each GP visit;
information sent to GP
Baseline, 3 & 12
months; BP, BMI,
cholesterol, alcohol,
smoking, exercise,
stroke knowledge, QoL
Completers: I: 91; C: 95 I:
signiﬁcant improvement
in BMI (p = 0.007) &
exercise (p<0.001); no
other signiﬁcant results
Kirk et al., 2013;
UK
I: n = 12, Male: 9
Age: 67.5 (SD 11.4);
C: n = 12, Male: 10;
Age: 66.8 (SD 7.3)
Group; Education &
exercise Theory: NR
One month post-event;
Weekly classes for 6
weeks (adapted)
Cardiac Rehabilitation
Programme
Baseline & 5 months
BP, BMI, waist-hip ratio
Completers: I: 12; C: 12 I:
signiﬁcant improvement
in activity levels
(p = 0.029); no other
signiﬁcant results
Kono et al. 2013;
Japan
I: n = 35, Male: 21
Age: 63.5 (SD 7.0);
C: n = 35, Male: 27;
Age: 63.4 (SD 11.4)
1 to 1; Exercise training,
advice & counseling; self-
education Behaviour
change theory
Post-discharge Weekly
exercise training for 24
weeks & self-
education; advice &
counseling baseline 3
& 6 months
Baseline, 3 & 6 months
Recurrent event, BP,
cholesterol, HbA1c,
weight, BMI, daily step
counts, daily salt intake,
diet, smoking, alcohol
Completers: I: 34; C: 34 I:
signiﬁcant decrease in
sBP (p< 0.001),
signiﬁcant increase in
HDL (p = 0,022) & daily
physical activity
(p = 0.012), & signiﬁcant
decrease in salt intake
(p<0.001); no other
signiﬁcant results
Maasland et al.
2007 The
Netherlands
I: n = NR, Male: 17
Age: 63 (SD 13); C:
n = NR, Male: 17;
Age: 65 (SD 12)
Individualized COSTA:
computer-supported health
education; Theory: NR
Time since onset: NR;
Individualized multi-
media computer
programme Frequency:
at individual’s
discretion
Baseline & 3 months
BP, cholesterol, weight
smoking, alcohol,
exercise, medication
compliance, stroke
knowledge
Completers: I: 27; C: 30
No signiﬁcant results
Peng et al. 2014
China
I: 1795, Male:
n = NR; Age: 61.5
(SD 11.5); C:
n = 2026, Male:
n = NR; Age: 60.3
(SD 11.7)
1 to 1; Medication, lifestyle
advice, education
(computer software);
Theory: NR
Time since onset: NR;
Frequency: NR;
Duration: NR
Baseline, 6 & 12
months; Recurrent
event; Medication
compliance; Programme
adherence
Completers: I: 1287; C:
1430; I: signiﬁcant
compliance with statins
(p = 0.006); no other
signiﬁcant results
(Continued)
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intervals [39]. In a ‘telephone support’ trial, Damush et al., (2011) made placebo telephone
calls that mimicked the intervention schedule [41]. Goldfinger et al., (2012) conducted risk fac-
tor assessments for control participants and made subsequent medical referrals, as appropriate
[23]. Kono et al., (2013), in their exercise and education trial, provided control participants
with usual care augmented by healthy lifestyle advice at baseline, 3 and 6 months [27].
Intervention duration ranged from ‘one off’ sessions to 6 weeks to 12 months. Five interven-
tions comprised a discrete educational intervention with no follow-up (other than for data col-
lection purpose) [22,23,29,31,36], one provided education and follow-up, in the form of
counselling, at 3 and 6 months post-intervention [27]. Ten interventions comprised an initial
session (e.g. assessment, education, information giving, counselling) followed by structured fol-
low-up [31–35,38–42]. Two were monthly interventions with lasted for 3 months [19,30], and
one computer-based intervention occurred on an individual basis [37]. Peng et al. [28] provid-
ed no details regarding intervention duration. Delivery methods included computer software,
one-to-one sessions, and group work. Of the 19 interventions that specified delivery format,
eight were delivered one-to-one [27,28,33–35,39,40,42]; four were delivered one-to-one and to
a carer/family member [19,20,30–32], five used groups/workshops [21–24,26, 29,36]—one of
these [23,24] used a peer-led model, the only example of peer-led delivery, and two used com-
puter software to deliver intervention content [37,38].
Five studies reported overt family involvement/participation in the intervention [19,20,
26,31,32,38]; three studies reported involving family members, but only if this was required
and/or desired by the stroke survivor [30,34,40].
Six of the twenty behavioral interventions reported that intervention design and/or delivery
was informed by a psychological theory of behavior change i.e. Social Cognitive Theory [43]
[26,33,41], the Health Belief Model [44] [21,22,30] and the Transtheoretical model [45] [34].
Other theories or approaches were also described including self-management [23,29,41], self-
regulation [26], and self-education [27].
Methodological Quality
Overall the risk of bias was high or unclear. Lack of detailed reporting resulted in many papers
being appraised as ‘unclear’. Principal sources of bias were block randomisation, poor alloca-
tion concealment, lack of allocation blinding and selective outcome reporting particularly in re-
lation to attrition. Sixteen papers reported data that could be used in meta-analysis. Of these,
Table 1. (Continued)
Authors, Year,
Country
Study participants Intervention type Theory/
Model
Intervention initiation,
frequency, duration
Data collection times
Outcomes of interest
Completers; Signiﬁcant
results at ﬁnal follow-up
Sit et al. 2007;
Hong Kong,
China
I: n = 107, Male: 55
Age: 62.8 (SD 10.3);
C: n = 83, Male: 50;
Age: 64.0 (SD 12.0)
Group; Education, group
work & individualized goal
setting; Self-management
Time since onset: NR;
Group meetings (2
hours) weekly for 8
weeks
Baseline & 3 months;
BP, cholesterol,
smoking, alcohol, diet,
exercise, medication
compliance, stroke
knowledge
Completers: I: 77; C: 70 I:
signiﬁcant improvements
in diet (p = 0.004), self-
monitoring of BP, stroke
knowledge & medication
compliance (all p<
0.001); C group
signiﬁcantly reduced
exercise; no other
signiﬁcant results
Wolfe et al.
2010; UK
I: n = 274, Male: 148;
Age: 20% >80 years;
C: n = 249, M: 131;
Age: 22% >80 years
Individualized; Stop
Stroke, tailored risk
management Theory: NR
10 weeks; Algorithm
applied at 10 weeks, 5
& 8 months
Baseline & 12–18
months; BP, smoking,
alcohol, medication
compliance
Completers: I: 273; C:
247; No signiﬁcant results
doi:10.1371/journal.pone.0120902.t001
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Table 2. Risk of Bias.
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Adie & James 2010 − ? − − + + +
Allen et al., 2009 − + + + + + +
Banet & Felchlia 1997 ? ? ? ? ? ? ?
Chanruengvanich et al., 2006 ? ? + − + − +
Damush et al., 2011 − ? ? − − − −
Eames et al., 2013 + ? − ? + + +
Ellis et al., 2005 + + + − + + +
Faulkner et al., 2013 + + ? + + + +
Flemming et al., 2013 − ? ? − − − −
Gilham & Endacott 2010 + + ? − −
Goldﬁnger et al., 2012 − ? ? ? ? ? ?
Hornnes et al., 2011 + ? + − − + +
Joubert et al., 2006 − − − − − − +
Joubert et al., 2009 ? − − − − + −
Kirk et al., 2013 ? ? − + + + +
Kono et al., 2013 + + ? + + + +
Maasland et al., 2007 + + + − − − −
Peng et al., 2014 − − ? ? ? ? ?
Sit et al., 2007 + − + − + − +
Wolfe et al., 2010 + + + − − + +
Key: + Low risk of bias;? Unclear risk of bias; − High risk of bias
doi:10.1371/journal.pone.0120902.t002
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10 performed ITT for all outcomes [20,22,25,27,30,33,34,36,38,39], 1 trial performed ITT for
mortality and vascular outcomes but not for medical adherence [28], in 1 trial it was unclear
what type of analysis was performed [26], and 4 trials did not use ITT analysis [32,35,37,42]
(see Table 2).
Meta-analyses: Physiological outcomes
Sufficient data were extracted to enable meta-analysis of a range of physiological outcomes of
interest including blood pressure, blood lipids, and anthropomorphic measurements.
Blood pressure. Data were pooled from 10 studies reporting blood pressure [20,22,25–
27,32,33,35,36,42] (Fig. 2). Compared to control, meta-analysis demonstrated that the mean ef-
fect of intervention on systolic blood pressure post-treatment was a significant reduction of
4.21 mmHg (−6.24 to −2.18, P<0.0001, I2 = 58%, 1,407 participants), however, there was mod-
erate heterogeneity. The mean effect on diastolic blood pressure was a significant reduction of
2.03 mmHg (−3.19 to −0.87, P = 0.006, I2 = 37%, 1,407 participants); heterogeneity
was moderate.
Blood lipids. Data were pooled from three studies reporting HDL results [22,27,36].
Meta-analysis demonstrated that the mean effect of intervention was a non-significant increase
of 0.11 mmol (−0.02 to 0.23, P = 0.11, I2 = 0%, 154 participants; Fig. 3). Data were pooled from
three studies reporting LDL results [25,27,42]. Meta-analysis demonstrated that the mean ef-
fect of intervention was a non-significant reduction of 0.02 mmol (−0.15 to 0.12, P = 0.37, I2 =
0%, 614 participants; Fig. 3). Data were pooled from six studies reporting total cholesterol
[20,22,26,32,33,36]. Meta-analysis demonstrated that there was a non-significant effect of in-
tervention compared to control on total cholesterol post-treatment (−0.07 mmol, −0.26 to
0.11, P = 0.42, I2 = 0%, 490 participants; Fig. 3). Data were pooled from two studies reporting
total cholesterol:HDL ratio [22,36]. Meta-analysis demonstrated that there was a non-
Fig 2. Forest Plot: Blood Pressure.
doi:10.1371/journal.pone.0120902.g002
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significant effect of intervention compared to control post-treatment (−0.19 mmol, −0.73 to
0.36, P = 0.50, I2 = 0%, 84 participants; Fig. 3).
Other blood tests. Data were pooled from three studies reporting fasting blood glucose
[22,36,42]. Meta-analysis demonstrated that there was no significant effect of intervention
compared to control post-treatment (−0.07 mmol/l, −0.16 to 0.02, P = 0.11, I2 = 0%, 120 partic-
ipants; Fig. 4). Data were pooled from two studies reporting high sensitivity-CRP (a cardiac
risk marker) [27,36]. Meta-analysis demonstrated that there was no significant effect of inter-
vention compared to control post-treatment (−0.03 mg/l, −0.08 to 0.02, P = 0.18, I2 = 0%, 94
participants; Fig. 5). Data were pooled from two studies reporting HbA1c [20,27]. Meta-analy-
sis demonstrated that there was no significant effect of intervention compared to control
post-treatment (−0.02, −0.28 to 0.24, P = 0.89, I2 = 63%, 172 participants; Fig. 6), however,
Fig 3. Forest Plot: Blood Lipids.
doi:10.1371/journal.pone.0120902.g003
Fig 4. Forest Plot: Fasting Blood Glucose.
doi:10.1371/journal.pone.0120902.g004
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heterogeneity was high. Data were pooled from two studies reporting fibrinogen results
[26,36]. Meta-analysis demonstrated that there was no significant effect of intervention com-
pared to control post-treatment (−0.19 g/l, −0.60 to 0.23, P = 0.37, I2 = 89%, 86 participants;
Fig. 7), however, heterogeneity was high.
Anthropomorphic measurements. Data were pooled from six studies reporting total
BMI results [22,27,32,36,37,42]. Meta-analysis demonstrated that post-treatment there was a
non-significant reduction 0.25 kg/m2 (−1.04 to 0.54, P = 0.53, I2 = 0%, 433 participants; Fig. 8).
Data were pooled from three studies reporting weight [22,27,33]. Meta-analysis demonstrated
that post-treatment there was a non-significant reduction of −1.53 kg (−4.48 to 1.43, P = 0.31,
I2 = 0%, 186 participants; Fig. 9). Data were pooled from two studies reporting waist circumfer-
ence [22,36]. Meta-analysis demonstrated that post-treatment there was a significant reduction
in waist circumference in intervention compared to control post-treatment (−6.69 cm, −11.44
to −1.93, P = 0.006, I2 = 0%, 96 participants; Fig. 10). Data were pooled from two studies re-
porting waist:hip ratio [22,36]. Meta-analysis demonstrated that post-treatment there was no
significant effect of intervention compared to control post-treatment (−0.02 cm, −0.06 to 0.01,
P = 0.17, I2 = 0%, 84 participants; Fig. 11).
Meta-analyses: Lifestyle behavior outcomes
No meta-analyses were possible for physical activity or stress management due to the heteroge-
neity of the outcome measures used and the outcomes reported. However, meta-analyses were
conducted for smoking status, diet, and medication compliance.
Smoking status. Data were pooled from five studies reporting current smoking status post
treatment [33,34,38,39,42]. Meta-analysis suggested there was no significant difference in odds
of an individual being a current smoker post-treatment in intervention group compared to
control (OR 1.15, 0.67 to 1.99, P = 0.61, I2 = 0%, 253 participants; Fig. 12). It should be noted
that four studies reported similar smoking levels at baseline in both groups. However, in the
study by Adie et al., (2010) over recruitment of smokers to the control group was acknowl-
edged [33].
Diet. Data were pooled from two studies reporting daily fruit and vegetable consumption
[34,36]. Meta-analysis suggested there was no significant difference in fruit and vegetable
Fig 5. Forest Plot: High Sensitivity-CRP.
doi:10.1371/journal.pone.0120902.g005
Fig 6. Forest Plot: HbA1c.
doi:10.1371/journal.pone.0120902.g006
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consumption in intervention group compared to control (0.46, −0.27 to 1.19, P = 0.22, I2 = 0%,
74 participants; Fig. 13).
Medication compliance. Data were pooled from two studies that had measured compli-
ance with all relevant, prescribed medication [20,39]. Meta-analysis suggested there was no sig-
nificant difference in odds of an individual complying with medication post-treatment in
intervention group compared to control (OR 1.10, 0.71 to 1.71, P = 0.67, I2 = 73%, 456 partici-
pants; Fig. 14), with high heterogeneity. However, some studies reported compliance with spe-
cific medications and the findings varied. Data were pooled from two studies reporting
compliance with antithrombotic medication [20,28]. Meta-analysis suggested there was a sig-
nificant increase in odds of an individual complying with antithrombotic medication post-
treatment in intervention group compared to control (OR 1.45, 1.21 to 1.75, P<0.0001, I2 =
0%, 2,792 participants; Fig. 14). Data were pooled from three studies reporting compliance
with antihypertensive medication [20,28,35]. Meta-analysis suggested there was no significant
difference in odds of an individual complying with antihypertensive medication post-treatment
in intervention group compared to control (OR 0.93, 0.76 to 1.13, P = 0.45, I2 = 0%, 2,028 par-
ticipants; Fig. 14). Data were pooled from three studies reporting compliance with statins
[20,28,42]. Meta-analysis suggested there was a significant difference in odds of an individual
complying with statin medication post-treatment in intervention group compared to control
(OR 2.53, 2.15 to 2.97, P< 0.00001, I2 = 0%, 2636 participants; Fig. 14).
Meta-analyses: Stroke knowledge
Due to the heterogeneity of the outcomes reported across the 20 studies and the heterogeneity
of the outcome measures used, there were insufficient data relating to changes in stroke knowl-
edge to allow meta-analysis.
Fig 7. Forest Plot: Fibrinogen.
doi:10.1371/journal.pone.0120902.g007
Fig 8. Forest Plot: Body Mass Index.
doi:10.1371/journal.pone.0120902.g008
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Meta-analyses: Psychosocial outcomes
Sufficient data were extracted from two studies [30,36] to enable pooling of anxiety data, as
measured using the Hospital Anxiety and Depression Scale [46]. Meta-analysis demonstrated
that post-treatment there was a significant reduction in anxiety in the intervention group com-
pared to control post-treatment (−1.20, −1.77 to −0.63, P<0.0001, I2 = 85%, 143 participants;
Fig. 15), however, heterogeneity was high.
Meta-analyses: Recurrent Events and Mortality
Recurrent TIA/Stroke. Data were pooled from four papers reporting recurrence of TIA/
stroke events [20,22,27,28]. Meta-analysis suggested that there was no significant difference in
odds of recurrence of TIA/stroke in the intervention group compared to control post-treat-
ment (OR 1.14, 0.81 to 1.60, P = 0.46, I2 = 68%, 4,053 participants; Fig. 16), however, heteroge-
neity was high.
Recurrent cardiac events. Data were pooled from four papers reporting recurrence of car-
diac events [20,22,27,28]. Meta-analysis suggested that there was a significant reduction in
odds of cardiac events in the intervention group compared to control post-treatment (OR 0.38,
0.16 to 0.88, P = 0.02, I2 = 0%, 4,053 participants; Fig. 17).
Mortality. Data were pooled from four papers reporting mortality [20,22,28,39]. Meta-
analysis suggested that there was no significant difference in odds of death in the intervention
group compared to control post-treatment (OR 0.91, 0.52 to 1.59, P = 0.74, I2 = 0%, 4,354 par-
ticipants; Fig. 18).
Meta-analyses: Long-term outcomes (sub-group analysis) 12-month
data
In terms of long-term effects of intervention, the longest follow-up time for which there were
sufficient data to enable meta-analyses was 12 months. Data from this time point were available
for only two outcomes i.e. BP and BMI.
Fig 9. Forest Plot: Weight.
doi:10.1371/journal.pone.0120902.g009
Fig 10. Forest Plot: Waist Circumference.
doi:10.1371/journal.pone.0120902.g010
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Data were pooled from three studies reporting blood pressure (systolic and diastolic) results
at 12-months [32,35,42]. Compared to control, meta-analysis demonstrated that the mean ef-
fect of intervention on systolic blood pressure post-treatment was a significant reduction of
4.19 mmHg (−7.46 to −0.93, P = 0.01, I2 = 0%, 525 participants; Fig. 19). Compared to control,
meta-analysis demonstrated that the mean effect of intervention on diastolic blood pressure
post-treatment was a significant reduction of 2.49 mmHg (−4.27 to −0.70, P = 0.01, I2 = 0%,
525 participants; Fig. 19).
Data were pooled from three studies reporting BMI results at 12-months [32,36,42]. Com-
pared to control, meta-analysis demonstrated that the mean effect of intervention on BMI
post-treatment was a non-significant reduction of 1.04 kg (−2.40 to 0.32, P = 0.13, I2 = 0%, 246
participants; Fig. 20).
Discussion
This systematic review and meta-analysis of multimodal interventions for the prevention of
secondary stroke included 20 RCTs (6,373 participants). Where data were available, meta-anal-
yses were conducted for physiological, lifestyle and psychosocial outcomes, and for recurrence
and mortality. Meta-analysis showed a significant effect of intervention on the reduction of sys-
tolic and diastolic blood pressure; these results had large numbers of participants. Positive
trends were noted in relation to blood lipids and anthropomorphic measures. In terms of life-
style factors, there was significant positive effect of intervention on medication compliance,
specifically for antithrombotic and statins, and both with large numbers of participants. A sig-
nificant positive effect was demonstrated in relation to anxiety, as measured by HADS;
Fig 11. Forest Plot: Waist:Hip Ratio.
doi:10.1371/journal.pone.0120902.g011
Fig 12. Forest Plot: Smoking.
doi:10.1371/journal.pone.0120902.g012
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however participant numbers were small, and this result should be treated with caution. And,
although meta-analysis demonstrated no significant effect of intervention on mortality or re-
currence of stroke/TIA, a significant reduction in recurrence of cardiac events was noted.
The review included only studies published in the English language and therefore may have
excluded other potentially relevant studies. And, as with any systematic literature review, it is
possible that the searches did not identify all relevant English language studies, however the
Fig 13. Forest Plot: Fruit and Vegetable Consumption.
doi:10.1371/journal.pone.0120902.g013
Fig 14. Forest Plot: Medication Compliance.
doi:10.1371/journal.pone.0120902.g014
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searches were extensive and included a comprehensive grey literature search strategy. A de-
tailed definition of ‘multimodal intervention’ was applied, however the studies included in the
review varied considerably in many respects, e.g. terms of length of intervention and follow up,
format, time post-stroke. This heterogeneity was not accounted for in the analyses, although
the 12-month follow-up data indicate that the effect of intervention persists beyond the short-
term. Meta-analysis was possible for only a limited range of outcomes of interest. There were
several reasons for this: lack of consistency in measures used across the studies; lack of use of/
availability of standardised outcomes measures, particularly in relation to behavioral outcomes;
lack of consistency of reporting across the studies e.g. mean and deviation or change; and selec-
tive reporting i.e. not reporting or making available the results of outcomes for which data
were collected. As described in the results section, data from only 16 of papers were included in
the various meta-analyses. Of these 1 trial performed ITT for mortality and vascular outcomes
but not for medical adherence, in 1 trial it was unclear what type of analysis was performed,
and 4 trials did not use ITT analysis. Although we acknowledge that poorer quality studies i.e.
studies that do not report ITT data, may introduce bias to the results, sensitivity analysis could
not be performed due to the small number of trials in some analysis. Therefore, if had we ex-
cluded trials based on quality, some analysis would not have been possible due to lack of data.
A further limitation of the studies included in the review was the lack of completeness of inter-
vention description. Such lack of detail prohibits replication or development of the interven-
tion by subsequent researchers and/or clinicians thus wasting already limited research
resources [47].
Due to the paucity of available data, all relevant studies were included, irrespective of meth-
odological quality. Most of the studies in this review rated poorly, however this, in part, reflects
some Risk of Bias criteria that, with hindsight, are not best suited to the appraisal of RCTs re-
porting behavioral interventions. For example, behavioral studies often rely on self-report to
measure outcomes, and participants and interventionists cannot be blinded to
the intervention.
Fig 15. Forest Plot: Anxiety.
doi:10.1371/journal.pone.0120902.g015
Fig 16. Forest Plot: TIA/Stroke Recurrence.
doi:10.1371/journal.pone.0120902.g016
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Meta-analysis showed a significant effect of intervention on reduction of blood pressure.
As indicated above, these analyses had large participant numbers and therefore are of worthy
of note. Controlling blood pressure to within recommended parameters (<140/85mmHg;
130/80 mmHg for people with diabetes) may reduce the risk of stroke by approximately 40%
[48,49]; therefore controlling blood pressure represents an important secondary prevention
outcome target.
In terms of blood lipids, meta-analysis demonstrated a non-significant reduction in total
cholesterol as a result of intervention; a finding echoed by Lennon et al., (2013) in their review
of lifestyle interventions, who noted that a lack of detailed reporting of data regarding full lipid
profiles excludes the possibility of looking at the effect of intervention on HDL ratio, which is a
more sensitive indicator of risk and risk reduction [13]. Contemporary guidelines suggest that
reduction of total cholesterol with a statin, reduces the relative risk of ischaemic stroke to 0.8
(0.70 to 0.92), indicating the importance of cholesterol as a secondary prevention outcome tar-
get, following TIA and ischaemic stroke [49].
In terms of lifestyle behavior, all included studies addressed smoking cessation, as might be
expected given the long-established importance of tobacco use as an independent risk factor
for stroke [6,50,51]. However, data from only five studies [33,34,38,39,42] were included in the
meta-analysis, which demonstrated no significant positive effect of intervention on smoking
status. All five interventions provided education and/or advice about smoking as a lifestyle risk
factor for stroke, and some made use of motivational interviewing or counselling approaches;
however, it was not clear, from what was reported, whether patients had been advised to use
pharmacotherapy (e.g. nicotine replacement therapy) to support a cessation attempt. This is
important as clinical guidelines suggest that smoking cessation interventions should include
both behavioral support and pharmacotherapy [52]. Again, while advice and “support” were
mentioned, there was little detail of what this actually meant. Brief smoking cessation interven-
tions are an important first step in the chain of support known to be effective in assisting
Fig 17. Forest Plot: Cardiac Events.
doi:10.1371/journal.pone.0120902.g017
Fig 18. Forest Plot: Mortality.
doi:10.1371/journal.pone.0120902.g018
Stroke Secondary Prevention: Systematic Review
PLOSONE | DOI:10.1371/journal.pone.0120902 March 20, 2015 18 / 25
cessation; however, more intensive support provided by cessation specialists is known to be the
most effective strategy in supporting an actual quit attempt [52]. In the UK it is recommended
that patients wishing to stop smoking be referred to a network of specially trained advisors
[52]. As discussed, little was written about the smoking cessation element of the various inter-
ventions and, similar to Lennon et al., (2013), we are concerned that the importance of the
smoking cessation message, and the need for pharmacotherapy and more intensive support to
assist a cessation attempt, may become lost in a multi-modal secondary prevention interven-
tion [13]. Finally, all but one of the studies relied on self-report of smoking status. The Russell
Standards recommend that all trials reporting on the effectiveness of smoking cessation inter-
ventions use objective measures of smoking status such as serum or salivary cotinine and/or ex-
pired carbon monoxide levels.
In terms of outcomes associated with lifestyle, meta-analysis for medication compliance
demonstrated significant positive effect of intervention. As indicated above, these meta-analy-
ses included large participant numbers, rendering these findings of greater interest to clinicians
and researchers. Optimal medication compliance is vital in the prevention of recurrent strokes
and other cardiovascular events [49]. However, the review found evidence of selective medica-
tion compliance i.e. participants were compliant with antithrombotics and statins but not with
Fig 19. Forest Plot: 12-month Blood Pressure.
doi:10.1371/journal.pone.0120902.g019
Fig 20. Forest Plot: 12-month Body Mass Index.
doi:10.1371/journal.pone.0120902.g020
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antihypertensives. Recent work by O’Carroll et al., (2013) found that predictors of poor adher-
ence (unintentional and intentional) to medication regimes included reduced cognitive func-
tion [53], a common consequence of stroke known to be associated with poor medication
adherence, and treatment beliefs i.e. perceived benefit versus perceived risk (side effects). Allen
et al., (2009) attempted to address unintentional non-compliance by providing pill organisers
and pre-packaged medication systems, as appropriate, and both Allen et al., (2009) and
Hornnes et al., (2011) in intensive, nurse-led interventions provided education regarding medi-
cation and the importance of compliance, with mixed effect [39,35]. However, O’Carroll et al.,
(2013) found that a brief intervention addressing erroneous beliefs about medication and
stroke improved medication adherence by 10% in a population of older adults following stroke
[53].
Data pooled from two small (n = 143 participants) studies [30,36] indicated that interven-
tion helped reduce anxiety, as measured by HADS. Although this is a positive outcome, the
small number of participants means it should be treated with caution. The lack of reporting of
psychosocial outcomes highlights need for further work in this area. In spite of the prevalence
of psychological consequences of stroke, there are few trials of effectiveness of behavioral inter-
ventions designed to address psychosocial issues after stroke. For example, despite widespread
recognition of mindfulness as a therapeutic intervention, a recent review of mindfulness-based
interventions following TIA/stroke identified only four studies, and these were of poor meth-
odological quality [54].
No meta-analyses were possible for any learning outcomes. Although, interventionists ac-
knowledged the important role of education and knowledge acquisition in relation to behavior
change, only four reported knowledge outcomes, and these used heterogeneous measures of ac-
quired knowledge. Knowledge, together with skills acquisition, is understood to have a role as a
precursor to behavior change, and education has been identified as a ‘source of behaviour’ [55].
Our qualitative review of participants’ perceptions of secondary prevention interventions de-
scribed acquisition of stroke-specific knowledge as a factor contributing to the development of
confidence [56], which is in turn a necessary precursor to engaging in and sustaining positive
lifestyle behavior change [57]. Joubert et al., (2009) noted that cholesterol levels were reduced
in participants who recalled receiving advice, and that this was statistically significant
(P = 0.005) [32]. Based on this evidence, they suggest that ‘advice translated into risk-factor
modification’ (p.282), although why this effect was demonstrated for cholesterol only, is un-
clear [32].
In terms of recurrence, there was a significant reduction in the recurrence cardiac events,
but not in reduction of the odds of TIA/stroke recurrence. The large numbers include in the
meta-analysis give weight to this significant finding. Given the commonalities in underlying
risk, this is perhaps an unexpected finding; however, it may reflect higher precision in measur-
ing and reporting cardiac events. In two studies the process for recording recurrent events is
unclear [22,28] and one study relied on self-report, acknowledging this as a limitation [20].
Only Kono et al., (2013) made efforts to verify recurrent events clinically [27]. Alternatively, it
might be argued that reduction in cardiac outcomes, rather than TIA/stroke outcomes is not
too surprising, as cardiac outcomes may be physiologically more amenable to secondary pre-
vention than stroke. Also, improved compliance with statins and antithrombotic medication
(rather than antihypertensives) is likely to favour cardiac prevention. However, this hypothesis
is tentative and should be regarded with caution.
Meta-analysis demonstrated no significant effect of intervention on mortality, perhaps an
unsurprising finding given the short follow up period reported in most papers. Evidence re-
garding effectiveness in terms of recurrence of stroke and other vascular events, and stroke
Stroke Secondary Prevention: Systematic Review
PLOSONE | DOI:10.1371/journal.pone.0120902 March 20, 2015 20 / 25
mortality, will only be generated by long-term follow-up of large cohorts; this review highlights
the need for such studies.
The limited effectiveness of the few studies that have been conducted may reflect essential
flaws in intervention design. In particular, a lack of theoretical underpinning and the failure to
draw on powerful family dynamics [58,59]. The lack of appropriate theory underpinning be-
havior change is surprising. Intervening to effect behavior change in the general population is
complex and challenging. Following stroke, residual impairments may vary in intensity and
complexity, and may present considerable barriers to engaging with lifestyle behavior change,
including formal, multimodal interventions. Evidence suggests that behavioral interventions
are more likely to be effective, across a broader range of outcomes, if they are grounded in be-
havior change theory and are delivered by healthcare professionals with appropriate training
[60]. In terms of family theory, a growing body of literature supports the active involvement of
family members in nursing interventions [61] and in post-stroke rehabilitation in particular
[62,63]. However, none of the studies in this review were overtly family-centred, only involving
a family member if required to support the participant in some aspect of the intervention. In
the cardiac field, where multimodal secondary prevention programmes are well established,
Euroaction, is an example of an overtly family-centred intervention that reduced the risk of
cardiovascular disease in families, who together made healthier food choices and became more
physically active [64].
Conclusions
In summary, there is growing evidence of the effectiveness of multimodal interventions follow-
ing TIA and stroke particularly in relation to achieving blood pressure reduction, medication
compliance and anxiety reduction. The findings from this review are complex and should be
interpreted with caution. They relate only to intervention outcomes and not to processes and
mechanisms of action. Future, large-scale trials RCTs should measure and report a wider range
of relevant outcomes, across the domains described here i.e. physiological, behavioral, psycho-
social, learning, and recurrence/mortality, using standardised measures validated with stroke
populations. Interventionists should provide greater detail regarding intervention design, deliv-
ery and fidelity, so that the essential work to understand the processes and mechanisms of ac-
tion can be undertaken.
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